Deutsche Bank
YMAB

Deutsche Bank’s Y-mAbs Therapeutics YMAB Stock Holding History

Deutsche Bank’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,803
Closed -$130K – 3751
2025
Q2 		$130K Hold
28,803
– – ﹤0.01% 3155
2025
Q1 		$128K Sell
28,803
-3,450
-11% -$20K ﹤0.01% 3126
2024
Q4 		$253K Buy
32,253
+11,059
+52% +$135K ﹤0.01% 2992
2024
Q3 		$279K Sell
21,194
-1,342
-6% -$17K ﹤0.01% 2753
2024
Q2 		$272K Buy
22,536
+3,897
+21% +$52.6K ﹤0.01% 2646
2024
Q1 		$303K Sell
18,639
-25
-0.1% -$337 ﹤0.01% 2604
2023
Q4 		$127K Buy
18,664
+509
+3% +$2.94K ﹤0.01% 3112
2023
Q3 		$98.9K Hold
18,155
– – ﹤0.01% 3166
2023
Q2 		$123K Sell
18,155
-5,468
-23% -$41K ﹤0.01% 3174
2023
Q1 		$118K Buy
23,623
+6,191
+36% +$25.3K ﹤0.01% 3248
2022
Q4 		$85.1K Buy
17,432
+246
+1% +$1.79K ﹤0.01% 3409
2022
Q3 		$248K Sell
17,186
-53,150
-76% -$880K ﹤0.01% 2821
2022
Q2 		$1.06M Sell
70,336
-234,706
-77% -$2.74M ﹤0.01% 2142
2022
Q1 		$3.62M Buy
305,042
+280,640
+1,150% +$2.88M ﹤0.01% 1550
2021
Q4 		$396K Buy
24,402
+1,545
+7% +$33K ﹤0.01% 2983
2021
Q3 		$653K Sell
22,857
-5,142
-18% -$162K ﹤0.01% 2868
2021
Q2 		$946K Buy
27,999
+1,329
+5% +$42.7K ﹤0.01% 2799
2021
Q1 		$806K Sell
26,670
-2,251
-8% -$92.3K ﹤0.01% 2809
2020
Q4 		$1.43M Buy
28,921
+6,707
+30% +$310K ﹤0.01% 2179
2020
Q3 		$853K Sell
22,214
-5,061
-19% -$201K ﹤0.01% 2310
2020
Q2 		$1.18M Sell
27,275
-27,314
-50% -$1.03M ﹤0.01% 2113
2020
Q1 		$1.43M Sell
54,589
-106,660
-66% -$3.1M ﹤0.01% 1903
2019
Q4 		$5.04M Buy
161,249
+155,044
+2,499% +$4.59M ﹤0.01% 1443
2019
Q3 		$160K Sell
6,205
-9,917
-62% -$253K ﹤0.01% 3318
2019
Q2 		$368K Buy
16,122
+7,348
+84% +$169K ﹤0.01% 3478
2019
Q1 		$228K Sell
8,774
-678
-7% -$14.9K ﹤0.01% 3927
2018
Q4 		$191K Buy
+9,452
New +$217K ﹤0.01% 3896

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's YMAB Position: Q3 2025 in Review

Deutsche Bank sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 28,803 shares — an estimated $130K sold.

Deutsche Bank first reported a position in YMAB in Q4 2018 and held it in 27 quarters. The position peaked at $5.04M in Q4 2019. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Deutsche Bank reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 28,803 Y-mAbs Therapeutics shares in Q3 2025, an estimated $130K.
  • Deutsche Bank first reported a position in Y-mAbs Therapeutics in Q4 2018 and held it in 27 quarters.
  • Deutsche Bank's Y-mAbs Therapeutics position peaked at $5.04M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.